A day after the Obama administration limited the ability of U.S. companies to do international deals to lighten tax burdens, Pfizer and Allergan terminated their $150 billion merger as other companies raced to assess the impact of the new rules.
This is a great example of an enterprise risk.
Please contact us at Contact@OxfordRMG.com or 410-472-6490 to speak with one of our captive research specialists!